The New England journal of medicine, 371(15), 1463-1464, 2014

Letrozole or clomiphene for infertility in the polycystic ovary syndrome

Richard S Legro , Hao Zhang , Eunice Kennedy Shriver NICHD Reproductive Medicine Network

Author affiliations (2)
  • Penn State Milton S. Hershey Medical Center ROR
  • Guangxi University ROR
DOI10.1056/NEJMc1409550 PMID25295506
Read at publisher

Abstract not indexed. Read at publisher

Topics

letrozole vs clomiphene PCOS infertility ovulation induction, Legro letrozole clomiphene polycystic ovary syndrome, aromatase inhibitor versus clomiphene citrate PCOS fertility, NICHD Reproductive Medicine Network PCOS trial, first line ovulation induction polycystic ovary syndrome, letrozole live birth rate PCOS randomized trial, clomiphene citrate resistance PCOS treatment alternatives, ovulation induction agents comparative effectiveness PCOS, polycystic ovary syndrome anovulatory infertility pharmacotherapy, letrozole clomiphene New England Journal Medicine
PMID 25295506 25295506 DOI 10.1056/NEJMc1409550 10.1056/NEJMc1409550

Cite this article

Legro, R. S., & Zhang, H. (2014). Letrozole or Clomiphene for Infertility in the Polycystic Ovary Syndrome. *The New England journal of medicine*, *371*(15), 1463-1464. https://doi.org/10.1056/NEJMc1409550

Related articles